161 related articles for article (PubMed ID: 18230366)
1. Recombinant hepatitis B surface antigen and anionic phospholipids share a binding region in the fifth domain of beta2-glycoprotein I (apolipoprotein H).
Mehdi H; Naqvi A; Kamboh MI
Biochim Biophys Acta; 2008 Mar; 1782(3):163-8. PubMed ID: 18230366
[TBL] [Abstract][Full Text] [Related]
2. A hydrophobic sequence at position 313-316 (Leu-Ala-Phe-Trp) in the fifth domain of apolipoprotein H (beta2-glycoprotein I) is crucial for cardiolipin binding.
Mehdi H; Naqvi A; Kamboh MI
Eur J Biochem; 2000 Mar; 267(6):1770-6. PubMed ID: 10712609
[TBL] [Abstract][Full Text] [Related]
3. Human beta 2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-beta 2-glycoprotein I antibodies.
Del Papa N; Sheng YH; Raschi E; Kandiah DA; Tincani A; Khamashta MA; Atsumi T; Hughes GR; Ichikawa K; Koike T; Balestrieri G; Krilis SA; Meroni PL
J Immunol; 1998 Jun; 160(11):5572-8. PubMed ID: 9605162
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus surface antigen binds to apolipoprotein H.
Mehdi H; Kaplan MJ; Anlar FY; Yang X; Bayer R; Sutherland K; Peeples ME
J Virol; 1994 Apr; 68(4):2415-24. PubMed ID: 8139027
[TBL] [Abstract][Full Text] [Related]
5. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).
McNeil HP; Simpson RJ; Chesterman CN; Krilis SA
Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4120-4. PubMed ID: 2349221
[TBL] [Abstract][Full Text] [Related]
6. Changes in beta 2-glycoprotein I antigenicity induced by phospholipid binding.
Wagenknecht DR; McIntyre JA
Thromb Haemost; 1993 Apr; 69(4):361-5. PubMed ID: 7684533
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro.
Di Simone N; Raschi E; Testoni C; Castellani R; D'Asta M; Shi T; Krilis SA; Caruso A; Meroni PL
Ann Rheum Dis; 2005 Mar; 64(3):462-7. PubMed ID: 15256379
[TBL] [Abstract][Full Text] [Related]
8. An altered form of apolipoprotein H binds hepatitis B virus surface antigen most efficiently.
Mehdi H; Yang X; Peeples ME
Virology; 1996 Mar; 217(1):58-66. PubMed ID: 8599236
[TBL] [Abstract][Full Text] [Related]
9. Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity.
Sheng Y; Sali A; Herzog H; Lahnstein J; Krilis SA
J Immunol; 1996 Oct; 157(8):3744-51. PubMed ID: 8871678
[TBL] [Abstract][Full Text] [Related]
10. Studies on specific interaction of beta-2-glycoprotein I with HBsAg.
Gao PJ; Piao YF; Liu XD; Qu LK; Shi Y; Wang XC; Yang HY
World J Gastroenterol; 2003 Sep; 9(9):2114-6. PubMed ID: 12970918
[TBL] [Abstract][Full Text] [Related]
11. Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects.
Vázquez-Mellado J; Llorente L; Richaud-Patin Y; Alarcón-Segovia D
J Autoimmun; 1994 Jun; 7(3):335-48. PubMed ID: 7916907
[TBL] [Abstract][Full Text] [Related]
12. Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human beta 2-glycoprotein I.
George J; Blank M; Gilburd B; Hojnik M; Shenkman B; Tamarin I; Varon D; Matsuura E; Koike T; Shoenfeld Y
Int Immunol; 1997 Jun; 9(6):913-21. PubMed ID: 9199975
[TBL] [Abstract][Full Text] [Related]
13. Specificities and characteristics of beta 2 glycoprotein I-induced antiphospholipid antibodies.
Gharavi AE; Sammaritano LR; Bovastro JL; Wilson WA
J Lab Clin Med; 1995 Jun; 125(6):775-8. PubMed ID: 7769372
[TBL] [Abstract][Full Text] [Related]
14. Epitope specificity of monoclonal anti-beta 2-glycoprotein I antibodies derived from patients with the antiphospholipid syndrome.
Wang MX; Kandiah DA; Ichikawa K; Khamashta M; Hughes G; Koike T; Roubey R; Krilis SA
J Immunol; 1995 Aug; 155(3):1629-36. PubMed ID: 7543528
[TBL] [Abstract][Full Text] [Related]
15. Some 'antiphospholipid antibodies' bind to beta 2-glycoprotein I in the absence of phospholipid.
Keeling DM; Wilson AJ; Mackie IJ; Machin SJ; Isenberg DA
Br J Haematol; 1992 Nov; 82(3):571-4. PubMed ID: 1486037
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to beta 2-glycoprotein-I: urea resistance, binding specificity, and association with thrombosis.
Vlachoyiannopoulos PG; Petrovas C; Tektonidou M; Krilis S; Moutsopoulos HM
J Clin Immunol; 1998 Nov; 18(6):380-91. PubMed ID: 9857282
[TBL] [Abstract][Full Text] [Related]
17. Genetics of apolipoprotein H (beta2-glycoprotein I) and anionic phospholipid binding.
Kamboh MI; Mehdi H
Lupus; 1998; 7 Suppl 2():S10-3. PubMed ID: 9814664
[TBL] [Abstract][Full Text] [Related]
18. "Anticardiolipin" autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding.
Roubey RA; Eisenberg RA; Harper MF; Winfield JB
J Immunol; 1995 Jan; 154(2):954-60. PubMed ID: 7814895
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface.
Pengo V; Biasiolo A; Fior MG
Thromb Haemost; 1995 Jan; 73(1):29-34. PubMed ID: 7537919
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of beta 2glycoprotein I binding to anionic phospholipids: a strategy for the development of antiphospholipid syndrome-specific drugs.
Kohles JD; Petersheim M; DeBari VA
Drug Des Discov; 1999 Nov; 16(3):227-36. PubMed ID: 10624568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
